Role of uropathogenic Escherichia coli OmpT in the resistance against human cathelicidin LL-37

FEMS Microbiology Letters

Volumn 345, Issue 1, 2013, Pages 64-71

  Brannon, John R ^a   Thomassin, Jenny Lee ^a   Desloges, Isabelle ^a   Gruenheid, Samantha ^a   Le Moual, Hervé ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Antimicrobial peptide; Cathelicidin; Outer membrane protease; Urinary tract infection; Uropathogenic Escherichia coli

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CHLORAMPHENICOL; KANAMYCIN; POLYMYXIN B; PROTEIN OMPT; PROTEINASE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; CONTROLLED STUDY; ENZYME ACTIVITY; GENE DELETION; MINIMUM INHIBITORY CONCENTRATION; MUTANT; NONHUMAN; OMPT GENE; PLASMID; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; UROPATHOGENIC ESCHERICHIA COLI;

ANTIMICROBIAL PEPTIDE; CATHELICIDIN; OUTER MEMBRANE PROTEASE; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL OUTER MEMBRANE PROTEINS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; HUMANS; PEPTIDE HYDROLASES; UROPATHOGENIC ESCHERICHIA COLI;

ESCHERICHIA COLI;

EID: 84880135079     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/1574-6968.12185     Document Type: Article

References (38)

1. Andersson P, Engberg I, Lidin-Janson G, Lincoln K, Hull R, Hull S & Svanborg C (1991) Persistence of Escherichia coli bacteriuria is not determined by bacterial adherence. Infect Immun 59: 2915-2921.
2. Brzuszkiewicz E, Bruggemann H, Liesegang H et al. (2006) How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains. P Natl Acad Sci USA 103: 12879-12884.
3. Chromek M, Slamova Z, Bergman P et al. (2006) The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med 12: 636-641.
4. Croxen MA & Finlay BB (2010) Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Microbiol 8: 26-38.
5. Donnenberg MS & Kaper JB (1991) Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector. Infect Immun 59: 4310-4317.
6. Edwards RA, Keller LH & Schifferli DM (1998) Improved allelic exchange vectors and their use to analyze 987P fimbria gene expression. Gene 207: 149-157.
7. Foxman B, Zhang L, Palin K, Tallman P & Marrs CF (1995) Bacterial virulence characteristics of Escherichia coli isolates from first-time urinary tract infection. J Infect Dis 171: 1514-1521.
8. Gruenheid S & Le Moual H (2012) Resistance to antimicrobial peptides in Gram-negative bacteria. FEMS Microbiol Lett 330: 81-89.
9. Hagan EC, Lloyd AL, Rasko DA, Faerber GJ & Mobley HL (2010) Escherichia coli global gene expression in urine from women with urinary tract infection. PLoS Pathog 6: e1001187.
10. Haiko J, Suomalainen M, Ojala T, Lahteenmaki K & Korhonen TK (2009) Breaking barriers - attack on innate immune defences by omptin surface proteases of enterobacterial pathogens. Innate Immun 15: 67-80.
11. Hancock RE & Sahl HG (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24: 1551-1557.
12. Hannan TJ, Totsika M, Mansfield KJ, Moore KH, Schembri MA & Hultgren SJ (2012) Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS Microbiol Rev 36: 616-648.
13. Hertting O, Holm A, Luthje P, Brauner H, Dyrdak R, Jonasson AF, Wiklund P, Chromek M & Brauner A (2010) Vitamin D induction of the human antimicrobial peptide cathelicidin in the urinary bladder. PLoS ONE 5: e15580.
14. Hritonenko V & Stathopoulos C (2007) Omptin proteins: an expanding family of outer membrane proteases in Gram-negative Enterobacteriaceae. Mol Membr Biol 24: 395-406.
15. Hull RA, Gill RE, Hsu P, Minshew BH & Falkow S (1981) Construction and expression of recombinant plasmids encoding type 1 or D-mannose-resistant pili from a urinary tract infection Escherichia coli isolate. Infect Immun 33: 933-938.
16. Kai-Larsen Y, Luthje P, Chromek M et al. (2010) Uropathogenic Escherichia coli modulates immune responses and its curli fimbriae interact with the antimicrobial peptide LL-37. PLoS Pathog 6: e1001010.
17. Kanamaru S, Kurazono H, Ishitoya S, Terai A, Habuchi T, Nakano M, Ogawa O & Yamamoto S (2003) Distribution and genetic association of putative uropathogenic virulence factors iroN, iha, kpsMT, ompT and usp in Escherichia coli isolated from urinary tract infections in Japan. J Urol 170: 2490-2493.
18. Kaper JB, Nataro JP & Mobley HL (2004) Pathogenic Escherichia coli. Nat Rev Microbiol 2: 123-140.
19. Le Sage V, Zhu L, Lepage C, Portt A, Viau C, Daigle F, Gruenheid S & Le Moual H (2009) An outer membrane protease of the omptin family prevents activation of the Citrobacter rodentium PhoPQ two-component system by antimicrobial peptides. Mol Microbiol 74: 98-111.
20. Lehmann J, Retz M, Harder J et al. (2002) Expression of human beta-defensins 1 and 2 in kidneys with chronic bacterial infection. BMC Infect Dis 2: 20.
21. Levine MM, Bergquist EJ, Nalin DR, Waterman DH, Hornick RB, Young CR & Sotman S (1978) Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive. Lancet 1: 1119-1122.
22. Mobley HL, Green DM, Trifillis AL, Johnson DE, Chippendale GR, Lockatell CV, Jones BD & Warren JW (1990) Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect Immun 58: 1281-1289.
23. Mulvey MA, Schilling JD & Hultgren SJ (2001) Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun 69: 4572-4579.
24. Rath A, Glibowicka M, Nadeau VG, Chen G & Deber CM (2009) Detergent binding explains anomalous SDS-PAGE migration of membrane proteins. P Natl Acad Sci USA 106: 1760-1765.
25. Roland K, Curtiss R 3rd & Sizemore D (1999) Construction and evaluation of a Δcya Δcrp Salmonella typhimurium strain expressing avian pathogenic Escherichia coli O78 LPS as a vaccine to prevent airsacculitis in chickens. Avian Dis 43: 429-441.
26. Roth BL, Poot M, Yue ST & Millard PJ (1997) Bacterial viability and antibiotic susceptibility testing with SYTOX green nucleic acid stain. Appl Environ Microbiol 63: 2421-2431.
27. Sambrook J, Fritsch EF & Maniatis T (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, New York, NY.
28. Sivick KE & Mobley HL (2010) Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect Immun 78: 568-585.
29. Spencer JD, Schwaderer AL, Dirosario JD et al. (2011) Ribonuclease 7 is a potent antimicrobial peptide within the human urinary tract. Kidney Int 80: 174-180.
30. Spencer JD, Hains DS, Porter E, Bevins CL, DiRosario J, Becknell B, Wang H & Schwaderer AL (2012) Human alpha-defensin 5 expression in the human kidney and urinary tract. PLoS ONE 7: e31712.
31. Spencer JD, Schwaderer AL, Wang H et al. (2013) Ribonuclease 7, an antimicrobial peptide upregulated during infection, contributes to microbial defense of the human urinary tract. Kidney Int 83: 615-625.
32. Thomassin JL, Brannon JR, Gibbs BF, Gruenheid S & Le Moual H (2012a) OmpT outer membrane proteases of enterohemorrhagic and enteropathogenic Escherichia coli contribute differently to the degradation of human LL-37. Infect Immun 80: 483-492.
33. Thomassin JL, Brannon JR, Kaiser J, Gruenheid S & Le Moual H (2012b) Enterohemorrhagic and enteropathogenic Escherichia coli evolved different strategies to resist antimicrobial peptides. Gut Microbes 3: 556-561.
34. Valore EV, Park CH, Quayle AJ, Wiles KR, McCray PB Jr & Ganz T (1998) Human beta-defensin 1: an antimicrobial peptide of urogenital tissues. J Clin Invest 101: 1633-1642.
35. Wang RF & Kushner SR (1991) Construction of versatile low-copy-number vectors for cloning, sequencing and gene expression in Escherichia coli. Gene 100: 195-199.
36. Wiegand I, Hilpert K & Hancock RE (2008) Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc 3: 163-175.
37. Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415: 389-395.
38. Zasloff M (2007) Antimicrobial peptides, innate immunity, and the normally sterile urinary tract. J Am Soc Nephrol 18: 2810-2816.